{"id":"https://openalex.org/W2031165071","doi":"https://doi.org/10.4088/jcp.v65n0216","title":"Double-Blind, Placebo-Controlled Assessment of Combined Clonazepam With Paroxetine Compared With Paroxetine Monotherapy for Generalized Social Anxiety Disorder","display_name":"Double-Blind, Placebo-Controlled Assessment of Combined Clonazepam With Paroxetine Compared With Paroxetine Monotherapy for Generalized Social Anxiety Disorder","alternate_titles":[],"publication_year":2004,"publication_date":"2004-02-15","ids":{"openalex":"https://openalex.org/W2031165071","doi":"https://doi.org/10.4088/jcp.v65n0216","mag":"2031165071","pmid":"https://pubmed.ncbi.nlm.nih.gov/15003080"},"language":"en","primary_location":{"id":"doi:10.4088/jcp.v65n0216","doi":"https://doi.org/10.4088/jcp.v65n0216","is_oa":false,"landing_page_url":"https://doi.org/10.4088/jcp.v65n0216","pdf_url":null,"source":{"id":"https://openalex.org/S17992710","display_name":"The Journal of Clinical Psychiatry","issn_l":"0160-6689","issn":["0160-6689","1534-8628","1555-2101"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4322614534","host_organization_name":"Physicians Postgraduate Press, Inc.","host_organization_lineage":["https://openalex.org/P4322614534"],"host_organization_lineage_names":["Physicians Postgraduate Press, Inc."],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Psychiatry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2031165071"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5033561394","display_name":"Sonja V. Batten","orcid":"https://orcid.org/0000-0002-7817-9763","observed_orcids":["https://orcid.org/0000-0002-7817-9763"]},"institutions":[{"id":"https://openalex.org/I4210099595","display_name":"VA San Diego Healthcare System","ror":"https://ror.org/00znqwq11","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210099595","https://openalex.org/I4210138663"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sonja V. Batten","raw_affiliation_strings":["Anxiety and Traumatic Stress Disorders Program, Psychiatry Service, VA San Diego Healthcare System, San Diego, CA, USA. sseedat@sun.ac.za"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Anxiety and Traumatic Stress Disorders Program, Psychiatry Service, VA San Diego Healthcare System, San Diego, CA, USA. sseedat@sun.ac.za","institution_ids":["https://openalex.org/I4210099595"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031117541","display_name":"Mihaela Aslan","orcid":"https://orcid.org/0000-0002-5041-010X","observed_orcids":["https://orcid.org/0000-0002-5041-010X"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mihaela Aslan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Paul K. Maciejewski","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Paul K. Maciejewski","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"Carolyn M. Mazure","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Carolyn M. Mazure","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":3.6452,"has_fulltext":false,"cited_by_count":85,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.91233056,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"65","issue":"2","first_page":"104","last_page":"109"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/generalized-social-anxiety-disorder","display_name":"generalized social anxiety disorder","score":0.996999979019165},{"id":"https://openalex.org/keywords/clonazepam","display_name":"clonazepam","score":0.996999979019165},{"id":"https://openalex.org/keywords/paroxetine","display_name":"paroxetine","score":1.0},{"id":"https://openalex.org/keywords/adjunctive-therapy","display_name":"adjunctive therapy","score":0.6759999990463257},{"id":"https://openalex.org/keywords/selective-serotonin-reuptake-inhibitors","display_name":"selective serotonin reuptake inhibitors","score":0.9350000023841858},{"id":"https://openalex.org/keywords/benzodiazepines","display_name":"benzodiazepines","score":0.8009999990463257},{"id":"https://openalex.org/keywords/avoidant-personality-disorder","display_name":"avoidant personality disorder","score":0.8080000281333923},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.734000027179718},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.531000018119812},{"id":"https://openalex.org/keywords/drug-tolerability","display_name":"drug tolerability","score":0.5989999771118164},{"id":"https://openalex.org/keywords/treatment-discontinuation","display_name":"treatment discontinuation","score":0.3610000014305115},{"id":"https://openalex.org/keywords/medication-tapering","display_name":"medication tapering","score":0.3790000081062317}],"concepts":[{"id":"https://openalex.org/C2777828372","wikidata":"https://www.wikidata.org/wiki/Q408471","display_name":"Paroxetine","level":4,"score":0.9293717741966248},{"id":"https://openalex.org/C2779426884","wikidata":"https://www.wikidata.org/wiki/Q407988","display_name":"Clonazepam","level":2,"score":0.9200716018676758},{"id":"https://openalex.org/C2777545354","wikidata":"https://www.wikidata.org/wiki/Q3557657","display_name":"Social anxiety","level":3,"score":0.6791427135467529},{"id":"https://openalex.org/C2779911313","wikidata":"https://www.wikidata.org/wiki/Q845224","display_name":"Generalized anxiety disorder","level":3,"score":0.6687338352203369},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.607563316822052},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.5967562794685364},{"id":"https://openalex.org/C2776317618","wikidata":"https://www.wikidata.org/wiki/Q544006","display_name":"Anxiety disorder","level":3,"score":0.5659124255180359},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.48239079117774963},{"id":"https://openalex.org/C2778173252","wikidata":"https://www.wikidata.org/wiki/Q83871","display_name":"Benzodiazepine","level":3,"score":0.4416186809539795},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.43465226888656616},{"id":"https://openalex.org/C2777669559","wikidata":"https://www.wikidata.org/wiki/Q407617","display_name":"Sertraline","level":4,"score":0.43231263756752014},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.39803576469421387},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.26734089851379395},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.21003323793411255},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002998","descriptor_name":"Clonazepam","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D002998","descriptor_name":"Clonazepam","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010552","descriptor_name":"Personality Assessment","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010698","descriptor_name":"Phobic Disorders","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D010698","descriptor_name":"Phobic Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010698","descriptor_name":"Phobic Disorders","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D014151","descriptor_name":"Anti-Anxiety Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D014151","descriptor_name":"Anti-Anxiety Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D017374","descriptor_name":"Paroxetine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D017374","descriptor_name":"Paroxetine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.4088/jcp.v65n0216","doi":"https://doi.org/10.4088/jcp.v65n0216","is_oa":false,"landing_page_url":"https://doi.org/10.4088/jcp.v65n0216","pdf_url":null,"source":{"id":"https://openalex.org/S17992710","display_name":"The Journal of Clinical Psychiatry","issn_l":"0160-6689","issn":["0160-6689","1534-8628","1555-2101"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4322614534","host_organization_name":"Physicians Postgraduate Press, Inc.","host_organization_lineage":["https://openalex.org/P4322614534"],"host_organization_lineage_names":["Physicians Postgraduate Press, Inc."],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Psychiatry","raw_type":"journal-article"},{"id":"pmid:15003080","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15003080","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of clinical psychiatry","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2020479370","https://openalex.org/W2073910294","https://openalex.org/W1994095895","https://openalex.org/W2361293308","https://openalex.org/W2148075979","https://openalex.org/W2082324164","https://openalex.org/W2080358195","https://openalex.org/W2091470293","https://openalex.org/W2554325214","https://openalex.org/W2006907321"],"abstract_inverted_index":{"BACKGROUND:":[0],"Generalized":[1],"social":[2,11],"anxiety":[3,12],"disorder":[4],"(GSAD)":[5],"is":[6,49,322,371],"a":[7,137,201,211,228,354],"pervasive":[8],"form":[9],"of":[10,17,58,113,123,131,139,167,186,194,222,256,294,313,373],"that":[13,285,325,353],"affects":[14],"approximately":[15],"5%":[16],"persons":[18],"in":[19,250,254,281,299,303,315,345,359],"the":[20,27,46,55,129,192,195,206,233,247,286,318,326,337],"community.":[21],"Among":[22],"evidence-based":[23],"pharmacologic":[24],"treatments":[25],"for":[26,52,107,148,232,356,364],"disorder,":[28,305],"selective":[29],"serotonin":[30],"reuptake":[31],"inhibitors":[32],"(SSRIs)":[33],"have":[34],"become":[35],"widely":[36],"used":[37],"and":[38,78,163],"are":[39],"known":[40],"to":[41,63,71,87,94,104,136,180,274,301,309,341],"be":[42,134],"efficacious.":[43],"Monotherapy":[44],"with":[45,60,81,100,227,296,361],"benzodiazepine":[47],"clonazepam":[48,59,90,295],"also":[50],"efficacious":[51],"GSAD,":[53],"but":[54],"adjunctive":[56,357],"use":[57],"an":[61,119,251,297],"SSRI":[62,366],"potentially":[64],"improve":[65],"outcomes":[66,332],"has":[67],"not":[68,263,307],"been":[69],"studied":[70],"date.":[72],"METHOD:":[73],"Twenty-eight":[74],"patients":[75,143,188,360],"(22":[76],"men":[77],"6":[79],"women)":[80],"DSM-IV-defined":[82],"GSAD":[83,362],"were":[84,175,244,277],"randomly":[85],"assigned":[86],"receive":[88],"double-blind":[89,114,197],"(or":[91],"placebo),":[92],"1.0":[93],"2.0":[95],"mg/day":[96],"(divided":[97],"b.i.d.)":[98],"along":[99],"open-label":[101,124],"paroxetine,":[102],"20":[103],"40":[105],"mg/day,":[106],"10":[108],"weeks.":[109],"A":[110],"2-week":[111],"taper":[112],"medication":[115],"was":[116,158,169,200,289,348],"followed":[117],"by":[118],"additional":[120],"8":[121],"weeks":[122],"paroxetine":[125,132],"treatment":[126],"(during":[127],"which":[128],"dose":[130],"could":[133],"increased":[135],"maximum":[138],"50":[140],"mg/day).":[141],"Twenty-three":[142],"(82%)":[144],"met":[145],"DSM-IV":[146],"criteria":[147],"avoidant":[149],"personality":[150],"disorder.":[151],"The":[152],"patients'":[153],"mean":[154,165],"+/-":[155,160,171],"SD":[156],"age":[157],"31.2":[159],"7.7":[161],"years,":[162],"their":[164],"duration":[166],"illness":[168],"12.1":[170],"5.8":[172],"years.":[173],"Data":[174],"gathered":[176],"from":[177],"August":[178],"2001":[179],"April":[181],"2002.":[182],"RESULTS:":[183],"Nineteen":[184],"(68%)":[185],"28":[187],"completed":[189],"treatment.":[190,270],"At":[191],"end":[193],"10-week":[196],"treatment,":[198],"there":[199,321],"trend":[202],"(p":[203],"<.06)":[204],"favoring":[205],"paroxetine/clonazepam":[207,287],"group,":[208],"who":[209],"had":[210,329],"79%":[212],"response":[213,230,368],"rate":[214,231],"(Clinical":[215],"Global":[216],"Impressions-Global":[217],"Improvement":[218],"scale":[219],"[CGI-I]":[220],"score":[221],"1":[223],"or":[224,262,369],"2)":[225],"compared":[226],"43%":[229],"paroxetine/placebo":[234],"group.":[235],"However,":[236],"no":[237],"significant":[238],"differences":[239,344],"on":[240,336],"other":[241,319],"outcome":[242],"measures":[243],"noted":[245],"between":[246],"2":[248],"groups":[249],"intent-to-treat":[252],"analysis,":[253],"terms":[255],"either":[257],"very":[258],"early":[259,265],"(2-4":[260],"weeks)":[261,267],"as":[264,334],"(5-10":[266],"responses":[268],"during":[269],"Dropout":[271],"rates":[272],"due":[273],"adverse":[275],"events":[276],"rare":[278],"(1":[279],"patient":[280],"each":[282],"group),":[283],"indicating":[284],"combination":[288],"well":[290],"tolerated.":[291],"CONCLUSION:":[292],"Coadministration":[293],"SSRI,":[298],"contrast":[300],"findings":[302],"panic":[304],"did":[306],"lead":[308],"more":[310],"rapid":[311],"resolution":[312],"symptoms":[314],"GSAD.":[316],"On":[317],"hand,":[320],"some":[323],"evidence":[324],"clonazepam-added":[327],"group":[328],"superior":[330],"global":[331],"(e.g.,":[333,363],"measured":[335],"CGI-I),":[338],"although":[339],"power":[340],"detect":[342],"such":[343],"this":[346],"study":[347],"small.":[349],"These":[350],"observations":[351],"suggest":[352],"role":[355],"benzodiazepines":[358],"augmenting":[365],"partial":[367],"nonresponse)":[370],"deserving":[372],"further":[374],"controlled":[375],"investigation.":[376]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2031165071","counts_by_year":[{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":8},{"year":2013,"cited_by_count":10},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
